To protect a top-selling drug from generic competition, Allergan PLC has sold the drug’s patents to an Indian tribe in upstate New York to block rivals from challenging the patents at the U.S. Patent and Trademark Office.
from WSJ.com: US Business http://ift.tt/2wQPUYs
via IFTTT
No comments:
Post a Comment